The article addresses prevalent cancer myths, emphasizing the complexity of cancer as a disease with over 200 types requiring varied treatments. It debunks misconceptions about a singular cure and highlights that many cancer cases arise from random genetic mutations. Overall,… Read More »Debunking popular cancer myths found on the internet
On August 19, 2026, Moderna and Merck announced that their personalized mRNA cancer vaccine, intismeran, significantly reduces melanoma recurrence and spread in a phase 3 trial. Combining intismeran with Merck’s Keytruda showed notable improvements in patient outcomes, marking a pivotal… Read More »New mRNA vaccine cuts recurrence and spread of melanoma
A recent study on a peptide vaccine targeting KRAS mutations demonstrates promising results for pancreatic cancer treatment. It elicited T-cell responses in 90% of patients, showing safety and persistence of responses for up to two years. These findings support further… Read More »Pancreatic cancer peptide vaccine shows promise in patients
Ivermectin, originally an antiparasitic drug, is now incorrectly promoted as a cancer treatment based on weak evidence. Despite some laboratory studies suggesting potential effects on cancer cells, no clinical trials confirm its efficacy in humans. Using ivermectin instead of standard… Read More »Ivermectin is now being touted as a cancer therapy
A recent study reveals that the HPV vaccine significantly reduces cervical cancer mortality to nearly zero in women under 30. With high vaccination coverage in England, cervical cancer deaths have decreased dramatically among young women, supporting the goal of eliminating… Read More »HPV vaccine cuts risk of dying from cervical cancer to almost zero
Recent developments indicate promising long-term results from clinical trials for an mRNA vaccine targeting pancreatic cancer, a notoriously hard-to-diagnose and treat disease. This individualized vaccine stimulates an immune response against cancer cells and may enhance patient outcomes when used in… Read More »Pancreatic cancer mRNA vaccine showing long-term success
Two recent studies criticize the ACIP’s new hepatitis B vaccine recommendations, which eliminate the birth dose. Experts warn this change could significantly increase hepatitis B infections, cancers, and deaths among infants, leading to greater healthcare costs. Maintaining universal birth vaccination… Read More »ACIP hepatitis B vaccine guidance will increase deaths, cancers
A recent study reveals that the HPV vaccine significantly reduces the risk of various cancers in men, mirroring its proven effectiveness in women. Despite this, vaccination rates in boys and young men remain low due to misconceptions about its importance.… Read More »HPV vaccine linked to a significantly lower cancer risk in men
William Makis, a former physician, faced legal action for practicing medicine without a license after losing his medical permit. A court found him in contempt for disregarding an order prohibiting him from presenting himself as a doctor and offering treatments… Read More »Court prohibits William Makis from treating cancer patients
A recent study indicates that cervical precancers related to HPV increase the risk of heart disease and mortality in young women. Individuals with prior cervical HSIL showed significantly higher cardiovascular risks. The HPV vaccine is recommended to prevent these precancers… Read More »HPV-related cervical precancers linked to risk of heart issues